Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization

Alzheimer’s disease (AD) is a neurodegenerative disorder associated with marked oxidative stress at the level of the brain. Recent studies indicate that increasing the antioxidant capacity could represent a very promising therapeutic strategy for AD treatment. Astaxanthin (AST), a powerful natural a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santonocito, Debora, Raciti, Giuseppina, Campisi, Agata, Sposito, Giovanni, Panico, Annamaria, Siciliano, Edy Angela, Sarpietro, Maria Grazia, Damiani, Elisabetta, Puglia, Carmelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913486/
https://www.ncbi.nlm.nih.gov/pubmed/33546352
http://dx.doi.org/10.3390/nano11020391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913486/
https://www.ncbi.nlm.nih.gov/pubmed/33546352
http://dx.doi.org/10.3390/nano11020391

Ejemplares similares